Cohance Lifesciences Share Price
Know More₹339.40-17.55 (-4.92%)
6-Feb-2026₹339.45-17.35 (-4.86%)
6-Feb-2026BSE : 543064
NSE : COHANCE
Sector : Health care
ISIN Code : INE03QK01018
- BSE
- NSE
- 1D
- 5D
- 1M
- 6M
- 1Y
- 2Y
- 5Y
- MAX
Last Updated: 06-Feb-2026
| Market Cap (₹ Cr) | 12,985 |
Traded Value (₹ Cr) | 1.10 |
Volume (Shares) | 32,289 |
Face Value (₹) | 1 |
52-Week High (₹) | - |
52-Week High Date | - |
52-Week Low (₹) | - |
52-Week Low Date | - |
All Time High (₹) | - |
All Time High Date | - |
All Time Low (₹) | - |
All Time Low Date | - |
Cohance Lifesciences Ltd
Cohance Lifesciences Ltd News
Cohance Lifesciences Ltd - Key Fundamentals
| PARAMETER | VALUES |
|---|---|
| Market Cap (₹ Cr) | 12,987 |
| EPS - TTM (₹) [C] | 8.19 |
| P/E Ratio (X) [C] | 41.45 |
| Face Value (₹) | 1 |
| Latest Dividend (%) | 100.00 |
| Latest Dividend Date | 09-Sep-2022 |
| Dividend Yield (%) | - |
| Book Value Share (₹) [C] | 99.01 |
| P/B Ratio (₹) [C] | 3.43 |
Funds Owning this Stock
| Scheme Name | Amount Invested (₹ Cr) | No Of Shares | Net Asset (%) |
|---|---|---|---|
| UTI-Flexi Cap Fund (IDCW) | 77.40 | 20,30,000 | 0.33 |
| UTI-Flexi Cap Fund (G) | 77.40 | 20,30,000 | 0.33 |
| UTI-Flexi Cap Fund - Direct (G) | 77.40 | 20,30,000 | 0.33 |
| UTI-Flexi Cap Fund - Direct (IDCW) | 77.40 | 20,30,000 | 0.33 |
| UTI-Healthcare Fund (G) | 15.83 | 4,15,044 | 1.50 |
| UTI-Healthcare Fund - Direct (G) | 15.83 | 4,15,044 | 1.50 |
| UTI-Healthcare Fund - Direct (IDCW) | 15.83 | 4,15,044 | 1.50 |
| UTI-Healthcare Fund (IDCW) | 15.83 | 4,15,044 | 1.50 |
| Nippon India Nifty Smallcap 250 Index Fund-Dir (IDCW) | 8.42 | 2,20,774 | 0.33 |
| Nippon India Nifty Smallcap 250 Index Fund (G) | 8.42 | 2,20,774 | 0.33 |
Load more
Research Reports
Stock Strength
| Today's Low/High (₹) | 334.50 355.00 |
| Week Low/High (₹) | 334.50 399.00 |
| Month Low/High (₹) | 334.50 513.00 |
Share Price Returns
| Period | BSE | NSE | SENSEX | NIFTY |
|---|---|---|---|---|
| 1 Week | -10.88% | -10.98% | 1.59% | 1.47% |
| 1 Month | -32.52% | -32.42% | -1.74% | -1.85% |
| 3 Month | -54.24% | -54.30% | 0.15% | 0.38% |
| 6 Month | -63.73% | -63.74% | 3.77% | 4.56% |
| 1 Year | -70.95% | -70.88% | 7.07% | 8.86% |
| 3 Year | -30.60% | -30.64% | 38.13% | 44.63% |
Company Info
Company Information
Chairman & Exec. Director : Vivek Sharma
Non-Exec & Non-Independent Dir : Vinod Padikkal
Independent Non Exe. Director : K G Ananthakrishnan
Independent Non Exe. Director : Matangi Gowrishankar
Independent Non Exe. Director : Vinod Rao
Independent Non Exe. Director : U B Pravin Rao
Independent Non Exe. Director : Jaishankar Krishnan
Non Executive Director : Pankaj Patwari
Non Executive Director : Shweta Jalan
CS / Compliance Officer / Legal Head : KUNDAN KUMAR JHA
Whole Time Director & Chief Financial Officer : Himanshu Agarwal
Registered Office: 8-2-334 SDE Serene Chambers, 3 Floor Avenue 7 Road No 5,Hyderabad,Telangana-500034 Ph: 91-40-23549414/1142/3311
Email:khrao@suvenpharm.com
FAQs about Cohance Lifesciences Ltd
1. What's the Cohance Lifesciences Ltd share price today?
Cohance Lifesciences Ltd share price was Rs 339.40 at close on 6th Feb 2026. Cohance Lifesciences Ltd share price was down by 4.92% from the previous closing price of Rs 356.95. Cohance Lifesciences Ltd share price trend:
- Last 1 Month: Cohance Lifesciences Ltd share price moved down by 32.52% on BSE.
- Last 3 Months: Cohance Lifesciences Ltd share price moved down by 54.24% on BSE.
- Last 12 Months: Cohance Lifesciences Ltd share price moved down by 70.95% on BSE.
- Last 3 Years: Cohance Lifesciences Ltd share price moved down by 30.60% on BSE.
2. How can I quickly analyse the performance of the Cohance Lifesciences Ltd stock?
The performance of the Cohance Lifesciences Ltd stock can be quickly analysed on the following metrics:
- The stock's PE is 41.45
- Price to book value ratio is 3.43
- The EPS (trailing 12 months) of the Cohance Lifesciences Ltd stock is Rs 8.19
3. What is the market cap of Cohance Lifesciences Ltd?
Cohance Lifesciences Ltd has a market capitalisation of Rs 12,985 crore.
5. Is the Cohance Lifesciences Ltd profitable?
On a consolidated basis, Cohance Lifesciences Ltd reported a profit of Rs 66.39 crore on a total income of Rs 571.17 crore for the quarter ended 2025.
6. Which are Cohance Lifesciences Ltd’s peers in the Health care sector?
Cohance Lifesciences Ltd’s top 5 peers in the Health care sector are Concord Biotech, Caplin Point Lab, Granules India, Cohance Life, Rubicon Research, OneSource Speci., Alivus Life.
7. Who owns how much in Cohance Lifesciences Ltd?
Key changes to the Cohance Lifesciences Ltd shareholding are as follows:
- Promoter holding in Cohance Lifesciences Ltd has gone down to 57.49 per cent as of Dec 2025 from 66.41 per cent as of May 2025.